John Hixson, MD
Professor
Neurology
School of Medicine

More specifically, I am interested in conducting clinical trials utilizing mobile health technologies (online diary systems and databases, electronic pillboxes) to improve clinical outcomes and cost efficiency. I am a part of the UCSF mHealth Group and the VA Innovations Initiative Patient-Facing Effort.

I am always eager to discuss these mobile health interests (mhealth) more specifically and am looking for collaborators!

From the UCSF Epilepsy Website:

Dr. John D. Hixson is a neurologist specializing in the evaluation and treatment of epilepsy and seizures. His research interests include emotion processing in temporal lobe epilepsy, antiepileptic drug management, and psychogenic nonepileptic seizures (PNES). Dr. Hixson also spends part of his time working on public advocacy and health service issues as relates to epilepsy care.

Dr. Hixson is an assistant professor of clinical neurology at UCSF. He earned a medical degree at Johns Hopkins University School of Medicine and completed a residency in neurology at the Hospital of the University of Pennsylvania in Philadelphia. Following residency, he conducted research and completed a fellowship in epilepsy and neurophysiology at the University of Iowa Hospitals and Clinics. Dr. Hixson serves on the policy advisory board of the Epilepsy Foundation of Northern California and on the advocacy advisory board of the American Academy of Neurology. He also serves as the medical editor-in-chief for the AAN News publication.

Specialities: Epilepsy, Neurology

Education: Johns Hopkins University School of Medicine, 2001

Residencies: Hospital of the University of Pennsylvania - Neurology, 2005

Fellowship: University of Iowa Hospitals and Clinics, 2006

• Focal nonmotor versus motor seizures: The impact on diagnostic delay in focal epilepsy.
  Epilepsia 2020 Pellinen J, Tafuro E, Yang A, Price D, Friedman D, Holmes M, Barnard S, Detyniecki K, Hegde M, Hixson J, Haut S, Kälviäinen R, French J, Human Epilepsy Project Co-Investigators
• Neuro-Oncology Practice Clinical Debate: long-term antiepileptic drug prophylaxis in patients with glioma.
  Neuro-oncology practice 2020 Stocksdale B, Nagpal S, Hixson JD, Johnson DR, Rai P, Shivaprasad A, Tremont-Lukats IW
• Assessment of the Predictive Value of Outpatient Smartphone Videos for Diagnosis of Epileptic Seizures.
  JAMA neurology 2020 Tatum WO, Hirsch LJ, Gelfand MA, Acton EK, LaFrance WC, Duckrow RB, Chen DK, Blum AS, Hixson JD, Drazkowski JF, Benbadis SR, Cascino GD, OSmartViE Investigators
• Digital and technological opportunities in epilepsy: Toward a digital ecosystem for enhanced epilepsy management.
  Epilepsy & behavior : E&B 2019 Shegog R, Braverman L, Hixson JD
• Digital tools for epilepsy: Opportunities and barriers.
  Epilepsy research 2019 Hixson JD, Braverman L
• Self-Management in Epilepsy Care: Untapped Opportunities.
  Federal practitioner : for the health care professionals of the VA, DoD, and PHS 2018 Ozuna J, Kelly P, Towne A, Hixson J
• Common data elements for epilepsy mobile health systems.
  Epilepsia 2018 Goldenholz DM, Moss R, Jost DA, Crone NE, Krauss G, Picard R, Caborni C, Cavazos JE, Hixson J, Loddenkemper T, Salazar TD, Lubbers L, Harte-Hargrove LC, Whittemore V, Duun-Henriksen J, Dolan E, …
• Is seizure frequency variance a predictable quantity?
  Annals of clinical and translational neurology 2018 Goldenholz DM, Goldenholz SR, Moss R, French J, Lowenstein D, Kuzniecky R, Haut S, Cristofaro S, Detyniecki K, Hixson J, Karoly P, Cook M, Strashny A, Theodore WH
• Does accounting for seizure frequency variability increase clinical trial power?
  Epilepsy research 2017 Goldenholz DM, Goldenholz SR, Moss R, French J, Lowenstein D, Kuzniecky R, Haut S, Cristofaro S, Detyniecki K, Hixson J, Karoly P, Cook M, Strashny A, Theodore WH, Pieper C
• Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia.
  Brain : a journal of neurology 2016 Vatsavayai SC, Yoon SJ, Gardner RC, Gendron TF, Vargas JN, Trujillo A, Pribadi M, Phillips JJ, Gaus SE, Hixson JD, Garcia PA, Rabinovici GD, Coppola G, Geschwind DH, Petrucelli L, Miller BL, Seeley WW
• Mobile health: the power of wearables, sensors, and apps to transform clinical trials.
  Annals of the New York Academy of Sciences 2016 Munos B, Baker PC, Bot BM, Crouthamel M, de Vries G, Ferguson I, Hixson JD, Malek LA, Mastrototaro JJ, Misra V, Ozcan A, Sacks L, Wang P
• Seizure diaries for clinical research and practice: limitations and future prospects.
  Epilepsy & behavior : E&B 2012 Fisher RS, Blum DE, DiVentura B, Vannest J, Hixson JD, Moss R, Herman ST, Fureman BE, French JA
• When physicians disagree: a case of nonconvulsive status epilepticus.
  Continuum (Minneapolis, Minn.) 2011 Hixson JD
• Stopping antiepileptic drugs: when and why?
  Current treatment options in neurology 2010 Hixson JD
• The effects of epilepsy and its treatments on affect and emotion.
  Neurocase 2009 Hixson JD, Kirsch HE
• Fear sensitivity and the psychological profile of patients with psychogenic nonepileptic seizures.
  Epilepsy & behavior : E&B 2006 Hixson JD, Balcer LJ, Glosser G, French JA
• Guidelines for new antiepileptic drug evaluation.
  Reviews in neurological diseases 2004 Hixson JD, French JA
• The distal elements, OCT and SPH, stimulate the formation of preinitiation complexes on a human U6 snRNA gene promoter in vitro.
  Nucleic acids research 1998 Kunkel GR, Hixson JD
• Intrinsic fluorescence studies of the chaperonin GroEL containing single Tyr --> Trp replacements reveal ligand-induced conformational changes.
  The Journal of biological chemistry 1996 Gibbons DL, Hixson JD, Hay N, Lund P, Gorovits BM, Ybarra J, Horowitz PM